Postextubation Stridor in Severe COVID-19.


Journal

Respiratory care
ISSN: 1943-3654
Titre abrégé: Respir Care
Pays: United States
ID NLM: 7510357

Informations de publication

Date de publication:
06 2022
Historique:
pubmed: 24 3 2022
medline: 26 5 2022
entrez: 23 3 2022
Statut: ppublish

Résumé

During the coronavirus disease 2019 (COVID-19) pandemic, 60-80% of patients admitted to ICU require mechanical ventilation for respiratory distress. We aimed to compare the frequency of postextubation stridor (PES) and to explore risk factors in COVID-19 subjects compared to those without COVID-19. We performed an observational retrospective study on subjects admitted for severe COVID-19 requiring mechanical ventilation > 48 h during the first and second waves in 2020 and compared these subjects to historical controls without COVID-19 who received mechanical ventilation > 48 h between 2016-2019. The primary outcome was the frequency of PES, defined as audible stridor within 2 h following extubation. Of the 134 subjects admitted with severe COVID-19 requiring mechanical ventilation, 96 were extubated and included and compared to 211 controls. The frequency of PES was 22.9% in the COVID-19 subjects and 3.8% in the controls PES affected nearly one-quarter of subjects with COVID-19, a proportion significantly higher than that seen in controls. Independent risk factors for PES were COVID-19, female sex, and tube mobilization or re-intubation or prone positioning. PES was associated with persistent viral shedding at the time of extubation.

Sections du résumé

BACKGROUND
During the coronavirus disease 2019 (COVID-19) pandemic, 60-80% of patients admitted to ICU require mechanical ventilation for respiratory distress. We aimed to compare the frequency of postextubation stridor (PES) and to explore risk factors in COVID-19 subjects compared to those without COVID-19.
METHODS
We performed an observational retrospective study on subjects admitted for severe COVID-19 requiring mechanical ventilation > 48 h during the first and second waves in 2020 and compared these subjects to historical controls without COVID-19 who received mechanical ventilation > 48 h between 2016-2019. The primary outcome was the frequency of PES, defined as audible stridor within 2 h following extubation.
RESULTS
Of the 134 subjects admitted with severe COVID-19 requiring mechanical ventilation, 96 were extubated and included and compared to 211 controls. The frequency of PES was 22.9% in the COVID-19 subjects and 3.8% in the controls
CONCLUSIONS
PES affected nearly one-quarter of subjects with COVID-19, a proportion significantly higher than that seen in controls. Independent risk factors for PES were COVID-19, female sex, and tube mobilization or re-intubation or prone positioning. PES was associated with persistent viral shedding at the time of extubation.

Identifiants

pubmed: 35318237
pii: respcare.09527
doi: 10.4187/respcare.09527
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

638-646

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 by Daedalus Enterprises.

Déclaration de conflit d'intérêts

The authors have disclosed no conflicts of interest.

Auteurs

Georges Abi Abdallah (GA)

Medical-Surgical Intensive Care Department Centre Hospitalier de Versailles - Site Andre Mignot, Le Chesnay, France.

Alexis Ferré (A)

Medical-Surgical Intensive Care Department Centre Hospitalier de Versailles - Site Andre Mignot, Le Chesnay, France.

Antoine Gros (A)

Medical-Surgical Intensive Care Department Centre Hospitalier de Versailles - Site Andre Mignot, Le Chesnay, France.

Christelle Simon (C)

Anaesthesia Department Centre Hospitalier de Versailles - Site Andre Mignot, Le Chesnay, France.

Fabrice Bruneel (F)

Medical-Surgical Intensive Care Department Centre Hospitalier de Versailles - Site Andre Mignot, Le Chesnay, France.

Stéphanie Marque-Juillet (S)

Microbiology Department, Centre Hospitalier de Versailles - Site Andre Mignot, Le Chesnay, France.

Stéphane Legriel (S)

Medical-Surgical Intensive Care Department Centre Hospitalier de Versailles - Site Andre Mignot, Le Chesnay, France; and University Paris-Saclay, UVSQ, INSERM, CESP, PsyDev Team, Villejuif, France.

Marine Paul (M)

Medical-Surgical Intensive Care Department Centre Hospitalier de Versailles - Site Andre Mignot, Le Chesnay, France. mpaul@ch-versailles.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH